A detailed history of Vanguard Group Inc transactions in Iridex Corp stock. As of the latest transaction made, Vanguard Group Inc holds 561,096 shares of IRIX stock, worth $779,923. This represents 0.0% of its overall portfolio holdings.

Number of Shares
561,096
Previous 561,096 -0.0%
Holding current value
$779,923
Previous $1.67 Million 27.57%
% of portfolio
0.0%
Previous 0.0%

Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

May 10, 2024

BUY
$2.35 - $3.1 $9,157 - $12,080
3,897 Added 0.7%
561,096 $1.67 Million
Q4 2022

Feb 10, 2023

BUY
$2.0 - $2.63 $488 - $641
244 Added 0.04%
557,199 $1.12 Million
Q1 2022

May 13, 2022

SELL
$3.99 - $6.42 $9,799 - $15,767
-2,456 Reduced 0.44%
556,955 $2.58 Million
Q4 2021

Feb 14, 2022

BUY
$5.62 - $9.37 $277,217 - $462,193
49,327 Added 9.67%
559,411 $3.42 Million
Q2 2021

Aug 13, 2021

BUY
$6.67 - $9.2 $3.4 Million - $4.69 Million
510,084 New
510,084 $3.6 Million

Others Institutions Holding IRIX

About IRIDEX CORP


  • Ticker IRIX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 15,985,600
  • Market Cap $22.2M
  • Description
  • IRIDEX Corporation, an ophthalmic medical technology company, provides therapeutic based laser systems, delivery devices, and consumable instrumentation to treat sight-threatening eye diseases in ophthalmology. It offers laser consoles, such as Cyclo G6 laser system for use in the treatment of glaucoma; IQ 532 and IQ 577 laser photocoagulation s...
More about IRIX
Track This Portfolio

Track Vanguard Group Inc Portfolio

Follow Vanguard Group Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Vanguard Group Inc, based on Form 13F filings with the SEC.

News

Stay updated on Vanguard Group Inc with notifications on news.